Drug use associated tricuspid valve infective endocarditis in pregnancy
Lin D, Mullan CW, Deshmukh U, Bahtiyar MO, Hosier H, Lipkind H, Abdel‐Razeq S, Ranjan S, Lancaster G, Pietras C. Drug use associated tricuspid valve infective endocarditis in pregnancy. Journal Of Cardiac Surgery 2020, 35: 2392-2395. PMID: 32720414, DOI: 10.1111/jocs.14888.Peer-Reviewed Original ResearchConceptsDrug useTricuspid valve infective endocarditisWeeks 6 days' gestationAppropriate intravenous antibioticsTricuspid valve endocarditisLife-threatening complicationsIntravenous drug useNeonatal critical careIntravenous antibioticsCesarean deliveryPerioperative periodValve endocarditisCardiac surgeryInfective endocarditisCritical careDays gestationPatient managementPregnant femalesEndocarditisMultidisciplinary collaborationPatientsGestationComplicationsPregnancySurgeryPsychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure
Mullan C, Caraballo C, Ravindra NG, Miller PE, McCullough M, Brown K, Aw TW, Gruen J, Clarke JD, Velazquez EJ, Geirsson A, Mori M, Desai NR, Ahmad T. Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure. JACC Heart Failure 2020, 8: 569-577. PMID: 32535119, DOI: 10.1016/j.jchf.2020.03.011.Peer-Reviewed Original ResearchConceptsPsychiatric comorbidityMajor psychiatric illnessNarcotic dependencePsychiatric illnessAdverse eventsHeart failureAlcohol abuseKansas City Cardiomyopathy Questionnaire scoreDrug useVentricular assist device implantationEnd-stage heart failureMechanically Assisted Circulatory SupportAssist device implantationEnd-stage heartRisk of rehospitalizationContinuous-flow LVADRisk of mortalityVulnerable patient populationVentricular assist deviceDevice-related infectionsInteragency RegistryLVAD recipientsSpecific psychiatric conditionsClinical outcomesPatient selection